Clinical Trials Sponsored by Nueva Vida, Inc.

Total 164 results

Georgetown University
Latinas Contra Cancer; Nueva Vida, Inc.; Gilda's Club NYC; SHARE

Completed

Nueva Vida Intervention for Latina Breast Cancer Survivors and Caregivers

Quality of Life | Breast Cancer

United States
Georgetown University
Virginia Commonwealth University; Basser Center for BRCA; Nueva Vida, Inc.; Capital... and other collaborators

Completed

Enhance the Use of Genetic Counseling and Testing in Latinas

Hereditary Breast and Ovarian Cancer Syndrome

United States
Duke University
Vida Health, Inc.

Completed

VIDA Mobile Health Cardiovascular Prevention Program

Coronary Artery Disease

United States
NoNO Inc.
Arbor Vita Corporation

Completed

Evaluating Neuroprotection in Aneurysm Coiling Therapy (ENACT)

Stroke

United States, Canada
Jessica Sieren
Vida Diagnostics, Inc

Not yet recruiting

Quantitative Lung Cancer Screening

Chronic Obstructive Pulmonary Disease | Pulmonary Disease | Cancer, Lung
Vidac Pharma
PharPoint Research, Inc.; Therapeutics, Inc.; Medistat Ltd., Israel

Completed

Study to Evaluate the Efficacy, Safety, and Tolerability of Topical VDA-1102 Ointment in Subjects With Actinic Keratosis (Phase2b)

Actinic Keratosis

United States
Lyndra Inc.
National Institute on Drug Abuse (NIDA)

Withdrawn

Study of LYN-014 in Individuals With Opioid Use Disorder Who Are Stable on Methadone Therapy

Opioid Use Disorder, Moderate
Inflexxion, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Field Trial of a Relapse Prevention Program for Adolescents Receiving Substance Use Treatment

Substance-Related Disorders

United States
Inflexxion, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Tobacco Cessation Field Study for Adults in Recovery - 1

Tobacco Use Disorder

United States
Adynxx, Inc.
National Institute on Drug Abuse (NIDA)

Withdrawn

Study to Evaluate a Preop Dose of Brivoligide Injection for Pain After Mastectomy in Patients With High PCS Scores

Pain, Postoperative
PainQx, Inc
National Institute on Drug Abuse (NIDA)

Completed

Development of a Medical Device Utilizing an EEG-Based Algorithm for the Objective Quantification of Pain

Chronic Pain

United States
Alkermes, Inc.
National Institute on Drug Abuse (NIDA)

Completed

ALK33BUP-101: Safety and Pharmacodynamic Effects of ALKS 33-BUP Administered Alone and When Co-administered With Cocaine

Cocaine Abuse

United States
PainQx, Inc
National Institute on Drug Abuse (NIDA)

Completed

Expanded Development of a Medical Device Utilizing an EEG-Based Algorithm for the Objective Quantification of Pain

Chronic Pain

United States
Indivior Inc.
National Institute on Drug Abuse (NIDA)

Completed

INDV-2000 First in Human

Opioid Dependence

United States
National Institute on Drug Abuse (NIDA)
Alkermes, Inc.

Completed

Phase 1 Study to Evaluate RDC-0313 Coadministered With Buprenorphine to Opioid-Experienced Healthy Adults

Substance-Related Disorders

United States
Embera NeuroTherapeutics, Inc.
National Institute on Drug Abuse (NIDA)

Completed

A Study to Evaluate EMB 001 in Subjects With Cocaine Use Disorder

Cocaine Use Disorder

United States
Embera NeuroTherapeutics, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Single Dose Crossover Comparative Bioavailability and Food Effect Study of Two EMB-001 Formulations

Cocaine Use Disorder

United States
Embera NeuroTherapeutics, Inc.
National Institute on Drug Abuse (NIDA)

Completed

A Study of Metyrapone and Oxazepam Combination Product (EMB-001) and Cocaine

Cocaine Use Disorder

United States
Syntrix Biosystems, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Omnitram Pharmacokinetic Study In Healthy Volunteers

Pain

United States
Clear Scientific, Inc.
National Institute on Drug Abuse (NIDA)

Recruiting

A Clinical Study to Evaluate the Safety of CS-1103 in Healthy Participants

Substance Use Disorders | Methamphetamine Abuse | Methamphetamine Intoxication

United States
Tempero Bio, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Multiple Ascending Dose Study of TMP-301 in Healthy Subjects

Healthy Volunteers | Substance Use Disorders | Cocaine Use Disorder

United States
Pharmaceutical Productions Inc.
National Institute on Drug Abuse (NIDA)

Completed

Pilot Pharmacokinetic Study of Investigational Sublingual Nicotine Tablet Versus COMMIT Nicotine Lozenge

Nicotine Pharmacokinetic Study

United States
Square2 Systems, Inc.
National Institute on Drug Abuse (NIDA)

Recruiting

Socializing a Science-Based Digital Therapeutic for Substance Use Disorders

Substance-Related Disorders | Substance Use Disorders

United States
SiteOne Therapeutics, Inc.
National Institute on Drug Abuse (NIDA)

Terminated

Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ST-2427

Acute, Post-operative Pain

United States
Affect Therapeutics, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Demonstration of a Digital Care Program for Methamphetamine Use Disorder

Methamphetamine Abuse

United States
Biotie Therapies Inc.
National Institute on Drug Abuse (NIDA)

Completed

Study of Safety and Potential Efficacy of SYN117 in Cocaine Dependent Volunteers

Cocaine Dependence

United States
Embera NeuroTherapeutics, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Single and Multiple Rising Dose Study of Safety and PK of Metyrapone/Oxazepam Combination (EMB-001)

Tobacco Use Disorder | Cocaine Use Disorder

United States
National Institute on Drug Abuse (NIDA)
Technical Resources International, Inc.; Promentis Pharmaceuticals, Inc.; Altasciences...

Not yet recruiting

SXC-2023 Cocaine Interaction Study

Cocaine Use Disorder

United States
Astellas Pharma Global Development, Inc.
National Institute on Drug Abuse (NIDA)

Completed

A Study to Assess the Effect of a Single Dose of ASP8062 on the Multiple Dose Safety, Tolerability and Pharmacokinetics of Buprenorphine/Naloxone in Participants With Opioid Use Disorder

Opioid Use Disorder

United States
Tonix Pharmaceuticals, Inc.
National Institute on Drug Abuse (NIDA); Premier

Not yet recruiting

Comparing Efficacy & Safety Of TNX-1300 To Placebo With UC For Treatment Of Acute Cocaine Intoxication In ED Subjects (CATALYST) (CATALYST)

Cocaine Use | Cocaine Abuse | Cocaine Adverse Reaction | Cocaine Intoxication | Cocaine Toxicity
AppliedVR Inc.
National Institute on Drug Abuse (NIDA); Geisinger Clinic

Completed

EaseVRx for the Reduction of Chronic Pain and Opioid Use

Chronic Low-back Pain

United States
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Facilitating the Implementation of Interim Methadone to Increase Treatment Access

Opioid-use Disorder

United States
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Extended Release Naltrexone for Opioid-Dependent Youth

Drug Dependence

United States
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine for Prisoners

Heroin Addiction

United States
National Institute on Drug Abuse (NIDA)
Friends Research Institute, Inc.

Completed

Evaluation of a Desipramine Ceiling in Cocaine Abuse - 1

Substance-Related Disorders | Cocaine-Related Disorders

United States
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Methadone Maintenance for Prisoners (MMP)

Heroin Addiction

United States
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Voucher-Based Incentives in a Prevention Setting (VIPS)

Substance-related Disorders

United States
Intra-Cellular Therapies, Inc.
National Institute on Drug Abuse (NIDA)

Recruiting

Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ITI 333 in Healthy Volunteers

Healthy Volunteers

United States
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)

Recruiting

Long-acting Naltrexone for Pre-release Prisoners

Opiate Addiction

United States
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)

Active, not recruiting

The Getting Off App for Methamphetamine-Using Gay and Bisexual Men

HIV/AIDS | Methamphetamine Abuse

United States
Syntrix Biosystems, Inc.
National Institute on Drug Abuse (NIDA); Celerion

Completed

A Randomized Study Investigating Oral Desmetramadol Dose Proportionality and Food Effect In Normal Human Subjects

Pain

United States
Intra-Cellular Therapies, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ITI 333 in Healthy Volunteers

Healthy Volunteers

United States
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Intensive Outpatient Versus Outpatient Treatment With Buprenorphine Among African Americans

Drug Dependence

United States
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Screening Brief Intervention Referral to Treatment (SBIRT) in New Mexico

Drug Abuse | HIV Risk Behavior

United States
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Long-term Behavior Change - 1

Amphetamine-related Disorders

United States
Astellas Pharma Global Development, Inc.
National Institute on Drug Abuse (NIDA)

Completed

A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Doses of ASP8062 With a Single Dose of Morphine in Recreational Opioid Using Participants

Opioid Use Disorder

United States
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)

Recruiting

Treating Polysubstance Use Using a Novel Digital Technology (POLY)

Opioid Use Disorder | Opioid Use | Cocaine Use Disorder | Cocaine Use

United States
Intra-Cellular Therapies, Inc.
National Institute on Drug Abuse (NIDA)

Recruiting

A PET Study Following a Single Oral Dose of ITI-333 in Healthy Subjects

Healthy Volunteers

United States
AppliedVR Inc.
National Institute on Drug Abuse (NIDA); Geisinger Clinic

Completed

RelieVRx for Total Knee Arthroplasty (TKA) for the Reduction of Acute Postoperative Pain and Opioid Use

Pain, Postoperative | Arthropathy of Knee | Opioid Use

United States
CrossComm, Inc.
National Institute on Drug Abuse (NIDA); Duke University

Active, not recruiting

Using Mobile Devices for Neurofeedback to Reduce Opioid Use in Chronic Pain

Chronic Pain | Opioid Use

United States

Clinical Trials Sponsored by Nueva Vida, Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saudi Arabia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations